Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies

Internal Medicine Journal

Volumn 44, Issue 6, 2014, Pages 601-604

  Page, M M ^a   Ekinci, E I ^b,c,d   Jones, R M ^b,c   Angus, P W ^b,c   Gow, P J ^b,c   O'Brien, R C ^b,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b AUSTIN HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Familial hypercholesterolaemia; LDL apheresis; Liver transplantation; Lomitapide; Mipomersen

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ATORVASTATIN; CHOLESTEROL; EZETIMIBE; FENOFIBRATE; ISOSORBIDE MONONITRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; ROSUVASTATIN; TACROLIMUS; WARFARIN; ANTILIPEMIC AGENT; AZETIDINE DERIVATIVE; HEPTANOIC ACID DERIVATIVE; LOW DENSITY LIPOPROTEIN; PYRROLE DERIVATIVE;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; APHERESIS; ARTICLE; BYPASS SURGERY; CADAVER DONOR; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG DOSE INCREASE; EXON; FAMILIAL HYPERCHOLESTEROLEMIA; GENE; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; MALE; MITRAL VALVE REPLACEMENT; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY VALVE REPLACEMENT; ROSS PROCEDURE; STRESS ECHOCARDIOGRAPHY; XANTHOMA; ADULT; BLOOD; CONSANGUINITY; CORONARY DISEASE; DEFICIENCY; DIET THERAPY; DRUG COMBINATION; GENETICS; HEART VALVE DISEASES; HEART VALVE REPLACEMENT; HOMOZYGOTE; HYPERLIPOPROTEINEMIA TYPE II; MULTIMODALITY CANCER THERAPY;

ADULT; AZETIDINES; BLOOD COMPONENT REMOVAL; CHOLESTEROL, LDL; COMBINED MODALITY THERAPY; CONSANGUINITY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FENOFIBRATE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEPTANOIC ACIDS; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, LDL; LIVER TRANSPLANTATION; MALE; PYRROLES; RECEPTORS, LDL;

EID: 84904642201     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12444     Document Type: Article

References (27)

1. Watts GF, Sullivan DR, Poplawski N, van Bockxmeer FM, Hamilton-Craig I, Clifton PM etal. Familial hypercholesterolaemia: a model of care for Australasia. Atheroscler Suppl 2011; 12: 221-263.
2. Kroon AA, van't Hof MA, Demacker PN, Stalenhoef AF. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels. Atherosclerosis 2000; 152: 519-526.
3. Thompson GR, Barbir M, Davies D, Dobral P, Gesindee M, Livingston M etal. Efficacy criteria and cholesterol targets for LDL apheresis. Atherosclerosis 2010; 208: 317-321.
4. Starzl TE, Bahnson HT, Hardesty RL, Iwatsuki S, Gartner JC, Bilheimer DW etal. Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984; 1: 1382-1383.
5. Sokal EM, Ulla L, Harvengt C, Otte JB. Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications. Transplantation 1993; 55: 432-433.
6. Shaw BW, Bahnson HT, Hardesty RL, Griffith BP, Starzl TE. Combined transplantation of the heart and liver. Ann Surg 1985; 202: 667-672.
7. Brush JE, Leon MB, Starzl TE, Gill C, Hoeg JM. Successful treatment of angina pectoris with liver transplantation and bilateral internal mammary bypass graft surgery in familial hypercholesterolemia. Am Heart J 1988; 116: 1365-1367.
8. Shrotri M, Fernando BS, Sudhindran S, Delriviere L, Watson CJ, Gibbs P etal. Long-term outcome of liver transplantation for familial hypercholesterolemia. Transplant Proc 2003; 35: 381-382.
9. Kawagishi N, Satoh K, Akamatsu Y, Sekiguchi S, Ishigaki Y, Oikawa S etal. Long-term outcome after living donor liver transplantation for two cases of homozygous familial hypercholesterolemia from a heterozygous donor. J Atheroscler Thromb 2007; 14: 94-98.
10. Küçükkartallar T, Yankol Y, Kanmaz T, Topaloǧlu S, Acarli K, Kalayoglu M. Liver transplantation as a treatment option for three siblings with homozygous familial hypercholesterolemia. Pediatr Transplant 2011; 15: 281-284.
11. Alkofer BJ, Chiche L, Khayat A, Deshayes JP, Lepage A, Saloux E etal. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report on the first case and review of the literature. Transplant Proc 2005; 37: 2250-2252.
12. Khalifeh M, Faraj W, Heaton N, Rela M, Sharara AI. Successful living-related liver transplantation for familial hypercholesterolemia in the Middle East. Transpl Int 2005; 17: 735-739.
13. Cienfuegos JA, Pardo F, Turrion VS, Ardaiz J, Mora NP, Escartin P etal. Metabolic effects of liver replacement in homozygous familial hypercholesterolemia. Transplant Proc 1987; 19: 3815-3817.
14. Ahualli L, Stewart-Harris A, Bastianelli G, Radlovachki D, Bartolomé A, Trigo PL etal. Combined cardiohepatic transplantation due to severe heterozygous familial hypercholesterolemia type II: first case in Argentina - a case report. Transplant Proc 2007; 39: 2449-2453.
15. El-Rassi I, Chehab G, Saliba Z, Alawe A, Jebara V. Fatal cardiac atherosclerosis in a child 10 years after liver transplantation: a case report and review. J Clin Lipidol 2011; 5: 329-332.
16. Ibrahim M, El-Hamamsy I, Barbir M, Yacoub MH. Translational lessons from a case of combined heart and liver transplantation for familial hypercholesterolemia 20 years post-operatively. J Cardiovasc Transl Res 2012; 5: 351-358.
17. Giakoustidis A, Cherian TP, Antoniadis N, Giakoustidis D. Combined cardiac surgery and liver transplantation: three decades of worldwide results. J Gastrointestin Liver Dis 2011; 20: 415-421.
18. Bahnson HT, Gordon RD. Transplantation of other organs with the heart. Cardiovasc Clin 1990; 20: 237-248.
19. Kakaei F, Nikeghbalian S, Kazemi K, Salahi H, Bahador A, Dehghani SM etal. Liver transplantation for homozygous familial hypercholesterolemia: two case reports. Transplant Proc 2009; 41: 2939-2941.
20. Lopez-Santamaria M, Migliazza L, Garnez M, Murcia J, Diaz-Gonzalez M, Camarena C etal. Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass. J Pediatr Surg 2000; 35: 630-633.
21. Barbir M, Khaghani A, Kehely A, Tan K-C, Mitchell A, Thompson GR etal. Normal levels of lipoproteins including lipoprotein(a) after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia. Q J Med 1992; 85: 807-812.
22. Geissler EK, Schlitt HJ. Immunosuppression for liver transplantation. Gut 2009; 58: 452-463.
23. Australia and New Zealand Liver Transplant Registry. ANZLT Registry Report 2011. Brisbane, Australia, 2011.
24. Page MM, Bell DA, Hooper AJ, Watts GF, Burnett JR. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children. Best Pract Res Clin Endocrinol Metab 2014. doi:10.1016/j.beem.2013.10.004
25. Raal FJ, Santos RD, Blom DJ, Marais AD, Charng M-J, Cromwell WC etal. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 375: 955-1052.
26. Bell DA, Hooper AJ, Watts GF, Burnett JR. Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia. Vasc Health Risk Manag 2012; 8: 651-659.
27. Sjouke B, Balak DM, Beuers U, Ratziu V, Stroes ES. Is mipomersen ready for clinical implementation? A transatlantic dilemma. Curr Opin Lipidol 2013; 24: 301-306.